Munich Startup · Jan 2026
Founder interview covering the company mission, product focus, workflow complexity, and the rationale for building a specialized AI platform for pricing and market access.
Company research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
Cellbyte is a Munich-based, seed-stage AI-native software company building a collaborative pricing and market access intelligence workspace for pharmaceutical teams. Its platform helps users research, analyze, and automate drug-launch workflows across regulatory, HTA, pricing, and internal data.
Primary product
AI-native platform for pharmaceutical Pricing & Market Access teams (Drug Explorer, Document Intelligence, Agentic Workflows, Data Vault)
Founded
2024
Headquarters
Westenriederstraße 10-12, 80331 Munich, Germany
Team size
11
Work style
Onsite
Industry
Software Development
Sub-industry
AI-native pharmaceutical pricing and market access intelligence software
Offices
Westenriederstraße 10-12, 80331 Munich, Germany (HQ)
München, Bavaria, Germany
San Francisco, California 94131, United States
Business model
B2B SaaS
enterprise software
annual platform contracts
Funding
Stage
seed
Total raised
$3.3M
Latest round
Seed · Nov 2025
Latest amount
$2.8M
Nov 2025 · Frontline Ventures
Jan 2022 · Y Combinator
People & investors
Leadership
Co-founder & Co-CEO
Co-founder & Co-CEO
Co-founder & CTO
Executive Operations Lead
Founding Engineer AI & ML
Work & culture
Small, international, founder-led team with a strong product and sales bias; mission-driven around accelerating pharma drug launches; high-agency, fast-growing, evidence- and trust-oriented, with an office-based Munich hub and an expanding U.S. presence.
Work style
Onsite
Compensation
Public job posts mention competitive salary plus equity, with one founding engineer role advertised at €120,000–€200,000 base plus equity. Founder posts also describe tier-1 compensation, high flexibility, and meaningful equity participation; sales roles mention uncapped commission.
Benefits
competitive salary
equity compensation
uncapped commission for sales roles
Urban Sports Club
Bike-Leasing
cozy office centrally located in Munich
meaningful equity participation
high flexibility
Product & market
Pricing
Sales-led enterprise SaaS with annual platform contracts
Differentiators
- —AI-native platform purpose-built for pharma Pricing & Market Access
- —over 100 connected data sources
- —analysis across clinical, pricing, HTA, and regulatory data
- —context-aware evidence generation rather than generic search or dashboards
- —human-in-the-loop workflows for high-stakes decisions
- —source-linked answers for auditability
- —multilingual document handling and translation
- —trusted by major pharma customers including Bayer
Technology
AI agents
document intelligence
human-in-the-loop workflows
secure data vault / internal knowledge base
multilingual document processing
source-linked evidence tracing
Microsoft workspace integrations
Google workspace integrations
GDPR-aligned data handling
ISO 27001 security program
SOC 2 Type 2 audit in progress
Customers
Bayer AG
global pharmaceutical companies
leading pharma brands
top-20 pharma customers
Competitors
Manifold AI
Komodo Health
Apheris
Exscientia
CytoReason
Confity
IQVIA
ZS Associates
Scale & contact
Estimated revenue
≈$330K ARR (estimated, Sep 2025)
Estimated monthly visits
2.5K
Traffic estimate as of Jul 2026
Latest news
Cellbyte · Nov 2025
Official seed-round announcement: Cellbyte raised $2.75M led by Frontline Ventures, with participation from Y Combinator, Pace Ventures, Saras Capital, and Springboard Health Angels; the company said it had six-figure ARR and contracts with major pharma customers.
FinSMEs · Nov 2025
Independent funding coverage confirming the $2.75M seed round, the lead investor, and the company’s pharma drug-launch product focus.
Tech Funding News · Nov 2025
Profiles Cellbyte’s AI platform for pharma launch workflows, the seed round, and claims about Bayer customers, market access, and launch-timeline reduction.
PharmaTimes · Nov 2025
Pharma industry coverage of the seed round, customer traction, and the company’s AI platform for market access and launch planning.
Jobs and careers at Cellbyte
0 jobs at Cellbyte
No open positions
Check back later for new openings